Arthur S. Kirsch
Arthur S. Kirsch is Chairman of the Board of Aralez Pharmaceuticals Inc. and served in this role with the company’s predecessor, POZEN Inc., since June 1, 2015 and on the Board since May 2004. He is chairman of the audit committee and a member of the compensation and governance/nominating committees. Mr. Kirsch has over 30 years of experience working in the equity capital markets and has extensive knowledge of the healthcare and life sciences field. Since 2005 he has been a Senior Advisor with GCA Savvian, LLC (formerly Perseus Group, LLC), an investment bank. Prior to GCA Savvian he was a founding member and managing director of Vector Securities, LLC, an investment and merchant banking firm. Mr. Kirsch has also held senior leadership positions at Prudential Vector Healthcare Group, a unit of Prudential Securities, Inc., and at Vector Securities International, Inc. Before joining Vector in 1995, he was president and chief executive officer of NatWest Securities U.S. and director of the Global Equity Division of Drexel Burnham Lambert. Mr. Kirsch also serves on the Board of Directors for Immunomedics.